Trastuzumab Emtansine Zydus Cadila Ujvira 100mg Injection

Trastuzumab emtansine( T- DM1) is an antibody- medicine conjugate that's effective and generally well permitted when administered as a single agent to treat advanced bone cancer.  The efficacity has now been demonstrated in randomized trials as first line, alternate line, and latterly than the alternate line treatment of advanced bone cancer. T- DM1 is presently being estimated as adjuvant treatment for early bone cancer. It has several mechanisms of action cohering of the anti-tumour goods of trastuzumab and those of DM1, a cytotoxicanti-microtubule agent released within the target cells upon declination of the human epidermal growth factor receptor- 2( HER2)- T- DM1 complex in lysosomes. We are a trusted exporter, trader, supplier, wholesaler and retailer of highly qualitative Trastuzumab Emtansine Zydus Cadila Ujvira 100mg Injection and offer the medicine at a high affordable rate.

Product details